PE20090073A1 - GINSENOSIDES AND EXTRACTS CONTAINING THEM COMBINED WITH DEXPANTHENOL - Google Patents

GINSENOSIDES AND EXTRACTS CONTAINING THEM COMBINED WITH DEXPANTHENOL

Info

Publication number
PE20090073A1
PE20090073A1 PE2008000652A PE2008000652A PE20090073A1 PE 20090073 A1 PE20090073 A1 PE 20090073A1 PE 2008000652 A PE2008000652 A PE 2008000652A PE 2008000652 A PE2008000652 A PE 2008000652A PE 20090073 A1 PE20090073 A1 PE 20090073A1
Authority
PE
Peru
Prior art keywords
amount
dexpanthenol
composition
ginsenosides
combined
Prior art date
Application number
PE2008000652A
Other languages
Spanish (es)
Inventor
Caroline Segond
Bony Raymond De
Armelle Magnet
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39616412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090073(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of PE20090073A1 publication Critical patent/PE20090073A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE: A) UN GINSENOSIDO TAL COMO G-Rb1 EN UNA CANTIDAD DE 0,001% A 6%, G-Rg1 EN UNA CANTIDAD DE 0,001% A 6%, G-Rd EN UNA CANTIDAD DE 0% A 1,5%, N-R1 EN UNA CANTIDAD DE 0% A 1,5%, G-Re EN UNA CANTIDAD DE 0% A 1% EN PESO DE LA COMPOSICION; B) UN ACIDO PANTOTENICO O UN DERIVADO DEL MISMO TAL COMO DEXPANTENOL EN UNA CANTIDAD DE 0,1% A 10% EN PESO DE LA COMPOSICION; Y C) UNA SUSTANCIA ACTIVA ADICIONAL TAL COMO GLICINA. DICHA COMPOSICION SE PRESENTA EN FORMA DE UNA SOLUCION ACUOSA, CREMA, GEL, BALSAMO, CHAMPU, PASTA, ENTRE OTROS, SIENDO UTIL EN EL TRATAMIENTO DE CICATRIZACION DE HERIDAS, DERMATITIS ATOPICA, PSORIASIS, ALERGIAS CUTANEASIT REFERS TO A PHARMACEUTICAL COMPOSITION CONTAINING: A) A GINSENOSIDE SUCH AS G-Rb1 IN AN AMOUNT OF 0.001% TO 6%, G-Rg1 IN AN AMOUNT OF 0.001% TO 6%, G-Rd IN AN AMOUNT OF 0% AT 1.5%, N-R1 IN AN AMOUNT OF 0% TO 1.5%, G-Re IN AN AMOUNT OF 0% TO 1% BY WEIGHT OF THE COMPOSITION; B) A PANTOTHENIC ACID OR A DERIVATIVE OF THE SAME SUCH AS DEXPANTHENOL IN AN AMOUNT OF 0.1% TO 10% BY WEIGHT OF THE COMPOSITION; AND C) AN ADDITIONAL ACTIVE SUBSTANCE SUCH AS GLYCINE. SUCH COMPOSITION IS PRESENTED IN THE FORM OF AN AQUEOUS SOLUTION, CREAM, GEL, BALSAM, SHAMPOO, PASTA, AMONG OTHERS, BEING USEFUL IN THE TREATMENT OF WOUND HEALING, ATOPIC DERMATITIS, PSORIASIS, CUTANEOUS ALLERGIES

PE2008000652A 2007-04-17 2008-04-15 GINSENOSIDES AND EXTRACTS CONTAINING THEM COMBINED WITH DEXPANTHENOL PE20090073A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07290470 2007-04-17

Publications (1)

Publication Number Publication Date
PE20090073A1 true PE20090073A1 (en) 2009-04-24

Family

ID=39616412

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000652A PE20090073A1 (en) 2007-04-17 2008-04-15 GINSENOSIDES AND EXTRACTS CONTAINING THEM COMBINED WITH DEXPANTHENOL

Country Status (3)

Country Link
CL (1) CL2008001065A1 (en)
PE (1) PE20090073A1 (en)
WO (1) WO2008125231A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102024572B1 (en) * 2013-04-24 2019-09-24 (주)아모레퍼시픽 External composition for skin containing Ginsenoside Rf
KR20160117015A (en) * 2015-03-31 2016-10-10 (주)아모레퍼시픽 SKIN EXTERNAL PREPARATION COMPRISING GINSENOSIDE Rg1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571503A (en) * 1995-08-01 1996-11-05 Mausner; Jack Anti-pollution cosmetic composition
AU3221599A (en) * 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
EP1921929A4 (en) * 2005-08-12 2009-08-05 Multi Formulations Ltd Supplemental dietary composition including caffeine, taurine and ginseng

Also Published As

Publication number Publication date
CL2008001065A1 (en) 2008-10-24
WO2008125231A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
EA201170876A1 (en) APPLICATION OF A COMPOSITION-APPROPRIATE COMPOSITION, IN SUBSTANCE, NOT CONTAINING PHARMACEUTICAL ACTIVE INGREDIENTS, FOR TREATING HUMAN SKIN
CL2016000530A1 (en) Treatment of osteoarthritis and pain (divisional sun. No. 2298-13).
MX2016006896A (en) Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics.
BR112015012565A2 (en) compound, cosmetic or pharmaceutical composition, and use of a compound
PH12014502778A1 (en) Antibody formulation
WO2012160180A3 (en) Pharmaceutical composition for administration to nails
ECSP10010352A (en) QUITOSANE GEL FOR DERMATOLOGICAL APPLICATIONS, PROCESS FOR OBTAINING AND USING THE SAME
RU2013147637A (en) COMPOSITION CONTAINING CELLULOSE, VEGETABLE OIL AND VOLVOUS SOLVENT AND ITS APPLICATION AS A BANDAGE
CO6710926A2 (en) N-heteroaryl compounds
BR112014021653A2 (en) TOPICAL FORMULATION, METHOD FOR WOUND TREATMENT AND METHOD TO MANUFACTURE A TOPICAL FORMULATION
TR201903940T4 (en) Dressing with extended release active ingredient.
CO6660486A2 (en) Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that present with a deficit of the maturation of the cornea envelope
CL2012002893A1 (en) Composition of at least one active ingredient of vegetable or synthetic origin thereof, or extract of plant origin containing it, in an aqueous solution, which also comprises lecithin as an encapsulating agent; medicine that understands it; method for its preparation; and its use to treat intestinal parasitosis.
BR112012029697A2 (en) tamarind seed polysaccharide for use in the treatment of inflammatory diseases
BR112016000092A2 (en) lipid nanoparticles for wound healing
PH12018500910A1 (en) Novel method of use and compositions
IL273329A (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
PE20090073A1 (en) GINSENOSIDES AND EXTRACTS CONTAINING THEM COMBINED WITH DEXPANTHENOL
AR097216A1 (en) COMPOSITION FOR TREATMENT AGAINST SKIN AGING
PE20091235A1 (en) COMPOSITIONS INCLUDING ASIAN ACID AND / OR MADECASIC ACID
MX357704B (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
EA201200754A1 (en) TRADITIONAL CHINESE DRUG, CONTAINING DAN-SHEN EXTRACTS (DANSHEN) AND SAN-KI (SANQI), AND ITS APPLICATION
HRP20150455T1 (en) Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis
AU2013378873B2 (en) Histo-equivalent bioplastic material
AR087488A1 (en) USE OF COMPOSITIONS TO DELAY THE START OF THE CATAGENA HAIR PHASE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal